2023
14 citations Research paper

Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent results

Sophia Linguiti, Jacob W. Vogel, Valerie J. Sydnor, Adam Pines, Nick Wellman, Allan I. Basbaum,

Summary & key facts

This paper reviewed brain imaging studies that looked at what happens in the brain right after people take classic psychedelics (like LSD or psilocybin), ketamine, or MDMA. The reviewers found some common brain changes across drugs, but they also pointed out that most studies used different methods, small groups of people, and different doses and timings. That means the patterns we see are interesting, but still preliminary and not settled.

Key facts:
  • The review pooled studies that scanned people’s brains during or soon after they took classic psychedelics, ketamine, or MDMA to see acute effects on brain activity and connectivity.
  • Many studies reported changes in the brain’s large-scale networks, especially the so-called default mode network (a set of brain regions involved in self-focused thinking), which often showed reduced tightness or coordination during drug effects.
  • Several studies found increased cross-talk between brain networks — in other words, brain regions that don’t usually work together started interacting more while people were under the drugs.
  • Emotional and sensory brain areas, including parts involved in feeling and processing images or sounds, often showed altered activity during the acute drug state.
  • The review stressed important methodological limits: many studies used small numbers of people, different scanning methods and analysis choices, different drug doses, and varied the timing of scans, which makes direct comparisons hard.
  • Because of those limitations, the reviewers said we should be cautious about strong conclusions. The patterns seen may help explain drug experiences, but they are not yet reliable enough to guide clinical decisions.
  • The paper highlights the need for larger, more standardized studies that use similar doses, timing, and analysis so researchers can tell which brain effects are real and which come from different methods.

Topics

Forensic Toxicology and Drug Analysis Neurotransmitter Receptor Influence on Behavior Psychedelics and Drug Studies

Categories

Clinical Psychology Psychology Social Sciences

Tags

Artifact (error) Cognitive psychology Functional magnetic resonance imaging Hallucinogen MDMA Neuroimaging Neuroscience Psilocybin Psychiatry Psychology

Substances

MDMA Psilocybin

Conditions & symptoms

Depression PTSD Feeling disconnected from others Sadness or low mood
Summaries and links are for general information and education only. They are not a substitute for reading the original publication or for professional medical, legal, or other advice. Always refer to the linked source for the full study.

Referencing articles

Ketamine for Mental Health
Science & Research
Ketamine for Mental Health 

Ketamine is reshaping mental health treatment for depression, PTSD, anxiety, chronic pain, and suicidal crisis.…

Written by: Cat Beer